These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28434376)

  • 21. MALVAC 2012 scientific forum: accelerating development of second-generation malaria vaccines.
    Vannice KS; Brown GV; Akanmori BD; Moorthy VS
    Malar J; 2012 Nov; 11():372. PubMed ID: 23140365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The GMZ2 malaria vaccine: from concept to efficacy in humans.
    Theisen M; Adu B; Mordmüller B; Singh S
    Expert Rev Vaccines; 2017 Sep; 16(9):907-917. PubMed ID: 28699823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Towards clinical development of a Pfs48/45-based transmission blocking malaria vaccine.
    Theisen M; Jore MM; Sauerwein R
    Expert Rev Vaccines; 2017 Apr; 16(4):329-336. PubMed ID: 28043178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pregnancy-associated malaria and the prospects for syndrome-specific antimalaria vaccines.
    Smith JD; Deitsch KW
    J Exp Med; 2004 Nov; 200(9):1093-7. PubMed ID: 15520241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The case for PfEMP1-based vaccines to protect pregnant women against Plasmodium falciparum malaria.
    Hviid L
    Expert Rev Vaccines; 2011 Oct; 10(10):1405-14. PubMed ID: 21988306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.
    Heppner DG; Kester KE; Ockenhouse CF; Tornieporth N; Ofori O; Lyon JA; Stewart VA; Dubois P; Lanar DE; Krzych U; Moris P; Angov E; Cummings JF; Leach A; Hall BT; Dutta S; Schwenk R; Hillier C; Barbosa A; Ware LA; Nair L; Darko CA; Withers MR; Ogutu B; Polhemus ME; Fukuda M; Pichyangkul S; Gettyacamin M; Diggs C; Soisson L; Milman J; Dubois MC; Garçon N; Tucker K; Wittes J; Plowe CV; Thera MA; Duombo OK; Pau MG; Goudsmit J; Ballou WR; Cohen J
    Vaccine; 2005 Mar; 23(17-18):2243-50. PubMed ID: 15755604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial.
    Alonso PL; Sacarlal J; Aponte JJ; Leach A; Macete E; Aide P; Sigauque B; Milman J; Mandomando I; Bassat Q; Guinovart C; Espasa M; Corachan S; Lievens M; Navia MM; Dubois MC; Menendez C; Dubovsky F; Cohen J; Thompson R; Ballou WR
    Lancet; 2005 Dec; 366(9502):2012-8. PubMed ID: 16338450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preventing pregnancy malaria. Simple vaccines that stop parasites lodging in the placenta may save thousands of lives.
    McCarthy M
    Lancet; 2004 Jan; 363(9403):132-3. PubMed ID: 14733187
    [No Abstract]   [Full Text] [Related]  

  • 29. Induction of anti-Plasmodium immunity following subpatent infection with live erythrocytic stages and drug cure.
    Stanisic DI; Good MF
    Methods Mol Biol; 2013; 923():535-47. PubMed ID: 22990803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human challenge models: tools to accelerate the development of malaria vaccines.
    Cooper MM; Loiseau C; McCarthy JS; Doolan DL
    Expert Rev Vaccines; 2019 Mar; 18(3):241-251. PubMed ID: 30732492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progress and challenges towards the development of malaria vaccines.
    Tetteh KK; Polley SD
    BioDrugs; 2007; 21(6):357-73. PubMed ID: 18020620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-Throughput Testing of Antibody-Dependent Binding Inhibition of Placental Malaria Parasites.
    Nielsen MA; Salanti A
    Methods Mol Biol; 2015; 1325():241-53. PubMed ID: 26450394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional genomic technologies applied to the control of the human malaria parasite, Plasmodium falciparum.
    Carucci DJ
    Pharmacogenomics; 2001 May; 2(2):137-42. PubMed ID: 11368752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccines against malaria.
    Ouattara A; Laurens MB
    Clin Infect Dis; 2015 Mar; 60(6):930-6. PubMed ID: 25452593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased susceptibility to Plasmodium falciparum infection in pregnant women with iron deficiency.
    Kabyemela ER; Fried M; Kurtis JD; Mutabingwa TK; Duffy PE
    J Infect Dis; 2008 Jul; 198(2):163-6. PubMed ID: 18500927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasmodium in the placenta: parasites, parity, protection, prevention and possibly preeclampsia.
    Duffy PE
    Parasitology; 2007; 134(Pt 13):1877-81. PubMed ID: 17958923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Towards functional antibody-based vaccines to prevent pre-erythrocytic malaria infection.
    Sack B; Kappe SH; Sather DN
    Expert Rev Vaccines; 2017 May; 16(5):403-414. PubMed ID: 28277097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malaria in pregnancy: pathogenesis and immunity.
    Rogerson SJ; Hviid L; Duffy PE; Leke RF; Taylor DW
    Lancet Infect Dis; 2007 Feb; 7(2):105-17. PubMed ID: 17251081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Live attenuated pre-erythrocytic malaria vaccines.
    Keitany GJ; Vignali M; Wang R
    Hum Vaccin Immunother; 2014; 10(10):2903-9. PubMed ID: 25483648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of naturally acquired IgG antibodies against Plasmodium falciparum serine repeat antigen-5 with reduced placental parasitemia and normal birth weight in pregnant Ugandan women: a pilot study.
    Owalla TJ; Palacpac NM; Shirai H; Horii T; Egwang TG
    Parasitol Int; 2013 Jun; 62(3):237-9. PubMed ID: 23395684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.